Epigenetics and the Environment
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
A bstract: DNA methylation and histone modification promote changes in chromatin structure that may affect gene expression in a heritable manner without directly altering the genome. As such, these phenomena are considered to be epigenetic in nature and are believed to contribute to the normal processes of human development but also to aberrant disease states such as cancer. Epigenetic processes probably contribute mechanistically to toxicant‐induced changes in gene expression and cancer. Nickel is a potent human carcinogen that has been shown to alter DNA methylation patterns and affect histone acetylation status. Both of these changes are associated with the proximity of the affected regions to heterochromatin. The two processes probably occur in concert in mammalian cells. However, in yeast cells, DNA methylation is absent, and nickel is capable of regulating gene expression through changes in acetylation of the lysine residues in the N terminal tail of histone H4. Arsenic is another important environmental carcinogen, and it is methylated during its metabolism. Hence, it has been proposed that arsenic metabolism may deplete intracellular methyl group stores and thereby lead to changes in DNA methylation that may be involved in carcinogenesis. However, the data concerning DNA methylation changes following arsenic exposure are equivocal, leading researchers to propose that DNA hypo‐ and hypermethylation are both important in the development of arsenic‐induced cancers. Heightened awareness by toxicologists of the importance of epigenetics in normal human development and in carcinogenesis should lead to the identification of other toxicants that manifest their effects, at least in part, via epigenetic mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
The Role of DNA Methylation in Mammalian Epigenetics
Jones, P. A., & Takai, D. (2001) · Science · doi:10.1126/science.1063852 · Cited by 2,070
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,275
Epigenetics: Regulation Through Repression
Wolffe, A. P., & Matzke, M. A. (1999) · Science · doi:10.1126/science.286.5439.481 · Cited by 1,239
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 994
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Ng, H.-H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., & Bird, A. (1999) · Nature Genetics · doi:10.1038/12659 · Cited by 936
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
Kitchin, K. T. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9157 · Cited by 792
Effects of DNA methylation on DNA-binding proteins and gene expression
Tate, P. H., & Bird, A. P. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90027-m · Cited by 737
Arsenic: health effects, mechanisms of actions, and research issues.
Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., et al. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107593 · Cited by 657
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Boyes, J., & Bird, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05055.x · Cited by 471
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
Lee, Y.-W., Klein, C. B., Kargacin, B., Salnikow, K., Kitahara, J., Dowjat, K., Zhitkovich, A., Christie, N. T., & Costa, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2547 · Cited by 367
Self-citationCytosine methylation determines hot spots of DNA damage in the human P 53 gene
Denissenko, M. F., Chen, J. X., Tang, M.-S., & Pfeifer, G. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3893 · Cited by 339
Mass, M. J., & Wang, L. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00008-2 · Cited by 309
The enigma of arsenic carcinogenesis: role of metabolism
Goering, P. (1999) · Toxicological Sciences · doi:10.1093/toxsci/49.1.5 · Cited by 274
Davis, C. D., Uthus, E. O., & Finley, J. W. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.12.2903 · Cited by 261
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W. C., de Bustros, A., Vertino, P. M., & Nelkin, B. D. (1991) · PubMed · Cited by 206
Epigenetic gene silencing in cancer
Tycko, B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9462 · Cited by 185
Senescence of Nickel-Transformed Cells by an X Chromosome: Possible Epigenetic Control
Klein, C. B., Conway, K., Wang, X. W., Bhamra, R. K., Lin, X., Cohen, M. D., Annab, L., Barrett, J. C., & Costa, M. (1991) · Science · doi:10.1126/science.1990442 · Cited by 183
Self-citationRelationships between chromatin organization and DNA methylation in determining gene expression
Jones, P. L., & Wolffe, A. P. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0134 · Cited by 176
Lübbert, M. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_9 · Cited by 169
Nickel compounds are novel inhibitors of histone H4 acetylation.
Broday, L., Peng, W., Kuo, M., Salnikow, K., Zoroddu, M. A., & Costa, M. (2000) · PubMed · Cited by 165
Self-citationp53 mutational spectra and the role of methylated CpG sequences
Pfeifer, G. P. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00022-1 · Cited by 161
Jirtle, R. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4453 · Cited by 149
Govindarajan, B., Klafter, R., Miller, M. S., Mansur, C., Mizesko, M., Bai, X., LaMontagne, K., & Arbiser, J. L. (2002) · Molecular Medicine · doi:10.1007/bf03401997 · Cited by 145
Romanov, G. A., & Vanyushin, B. F. (1981) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(81)90156-8 · Cited by 143
Chen, H., Liu, J., Zhao, C. Q., Diwan, B. A., Merrick, B. A., & Waalkes, M. P. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9253 · Cited by 142
Zhong, C., & Mass, M. J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00365-4 · Cited by 128
Feinberg, A. P. (2001) · Springer eBooks · doi:10.1007/3-540-30683-8_653 · Cited by 127
Carcinogenic Activity of Particulate Nickel Compounds Is Proportional to Their Cellular Uptake
Costa, M., & Mollenhauer, H. H. (1980) · Science · doi:10.1126/science.7394519 · Cited by 126
Self-citationGene Silencing by Methyl‐CPG‐Binding Proteins
Nan, X., Cross, S., & Bird, A. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470515501.ch2 · Cited by 122
Epigenetics and DNA Methylation Come of Age in Toxicology
Watson, R. E., & Goodman, J. I. (2002) · Toxicological Sciences · doi:10.1093/toxsci/67.1.11 · Cited by 120
Costa, M., Simmons-Hansen, J., BEDROSSIAN, C. W. M., Bonura, J., & Caprioli, R. M. (1981) · PubMed · Cited by 120
Self-citationMammalian Methyltransferases and Methyl-CpG-Binding Domains: Proteins Involved in DNA Methylation
Hendrich, B., & Bird, A. P. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_4 · Cited by 113
Altered DNA Methylation: A Secondary Mechanism Involved in Carcinogenesis
Goodman, J. I., & Watson, R. E. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092001.141143 · Cited by 111
Bal, W., Liang, R., Lukszo, J., Lee, S.-H., Dizdaroğlu, M., & Kasprzak, K. S. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000044l · Cited by 110
Cytosine methylation and human cancer
Warnecke, P. M., & Bestor, T. H. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00012 · Cited by 108
Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds.
Fletcher, G. G., Rossetto, F. E., Turnbull, J. D., & Nieboer, E. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s369 · Cited by 106
Zoroddu, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00066-0 · Cited by 104
Bal, W., Lukszo, J., Białkowski, K., & Kasprzak, K. S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980051y · Cited by 103
Pharmacokinetics, Metabolism, and Carcinogenicity of Arsenic
Pott, W. A., Benjamin, S. A., & Yang, R. S. H. (2001) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4613-0107-3_3 · Cited by 98
Immortalization of normal human kidney epithelial cells by nickel(II).
Tveito, G., Hansteen, I. L., Dalen, H., & Haugen, Å. (1989) · PubMed · Cited by 92
DNA Methylation as a Target for Drug Design
Bender, C. M., Zingg, J.-M., & Jones, P. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011946030404 · Cited by 87
Behind the Scenes of Gene Expression
Pennisi, E. (2001) · Science · doi:10.1126/science.293.5532.1064 · Cited by 83
Oncogenic mechanisms mediated by DNA methylation
Laird, P. W. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01019-8 · Cited by 82
Mutation Hotspots and DNA Methylation
Pfeifer, G. P., Tang, M.-S., & Denissenko, M. F. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_1 · Cited by 79
Costa, M., Abbracchio, M. P., & Simmons-Hansen, J. (1981) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90234-6 · Cited by 78
Self-citationCosta, M., & Mollenhauer, H. H. (1980) · PubMed · Cited by 77
Self-citationNonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells.
Conway, K., & Costa, M. (1989) · PubMed · Cited by 76
Self-citationEvans, R. M., Davies, P. J., & Costa, M. (1982) · PubMed · Cited by 73
Self-citationTransgenic chinese hamster V79 cell lines which exhibit variable levels of gpt mutagenesis
Klein, C. B., Rossman, T. G., & Skopek, T. R. (1990) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850160102 · Cited by 64
DNA Methylation, Genomic Imprinting and Cancer
Feinberg, A. P. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_6 · Cited by 63
Wolffe, A. P. (1998) · The Journal of Experimental Zoology · doi:10.1002/(sici)1097-010x(199809/10)282:1/2<239::aid-jez25>3.0.co;2-n · Cited by 58
Bal, W., Lukszo, J., & Kasprzak, K. S. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950157i · Cited by 54
Nickel enhances telomeric silencing in Saccharomyces cerevisiae
Broday, L., Cai, J. Q., & Costa, M. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(99)00018-2 · Cited by 53
Self-citationSutherland, J. E., Peng, W., Zhang, Q., & Costa, M. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00163-4 · Cited by 48
Self-citationImprinted Genes as Potential Genetic and Epigenetic Toxicologic Targets
Murphy, S. K., & Jirtle, R. L. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s15 · Cited by 46
Mayer, C., Klein, R., Wesch, H., & Schmezer, P. (1998) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(98)00140-5 · Cited by 46
Zhang, Q. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00280-1 · Cited by 44
Interaction of Nickel(II) with Histones:In VitroBinding of Nickel(II) to the Core Histone Tetramer
Bal, W., Karantza, V., Moudrianakis, E. N., & Kasprzak, K. S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1137 · Cited by 40
Mutagenicity of soluble and insoluble nickel compounds at the gpt locus in G12 chinese hamster cells
Lee, Y. W., Pons, C., Tummolo, D. M., Klein, C. B., Rossman, T. G., & Christie, N. T. (1993) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850210408 · Cited by 40
Tycko, B. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69111-2_7 · Cited by 31
Cited by
Phenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613
“Environmental toxins such as heavy metals disrupt DNA methylation and chromati”
BackgroundTranscriptional and epigenetic mechanisms of addiction
Robison, A. J., & Nestler, E. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3111 · Cited by 993
Salnikow, K., & Zhitkovich, A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700198a · Cited by 924
Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD
Yehuda, R., & LeDoux, J. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.006 · Cited by 783
Epigenetics and human disease: translating basic biology into clinical applications
Rodenhiser, D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050774 · Cited by 473
Metadata
- Authors
- SUTHERLAND, J. E., & COSTA, M.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 983
- Issue
- 1
- Pages
- 151-160
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2078084280
- Cited by
- 261
- References
- 77
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.